CompletedNCT03684447
Propofol Dose and Brain Markers in Treatment-Resistant Depression
About this title
Read the official source — NCT03684447Medication studyAges 18–55United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- Salt Lake CitySee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: April 21, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 32
- Sponsor
- University of Utah
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT03684447
- Official title
Show the full official title
Neural and Antidepressant Effects of Propofol
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Salt Lake City
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Utah, a university.
Did this study involve medication?
Yes. The study involved medication, including Propofol.
Who was this study for?
Listed age limits: 18 years to 55 years.
